Chowist Web Search

Search results

1. Results From The WOW.Com Content Network

2. Glucerna - Wikipedia

   en.wikipedia.org/wiki/Glucerna

   Glucerna is the brand name of a family of tube feeding formula, bottled or canned shakes, and snack bars manufactured by Abbott Laboratories. [ 1] It was introduced to the public in 1989. [ 2] These medical nutritional products are meant for people with diabetes and are promoted for their ability to satisfy hunger without causing rapid ...

3. Diabetes medication - Wikipedia

   en.wikipedia.org/wiki/Diabetes_medication

   Diabetes medication. Drugs used in diabetes treat diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin, most GLP-1 receptor agonists ( liraglutide, exenatide, and others), and pramlintide, all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic ...

4. Dipeptidyl peptidase-4 inhibitor - Wikipedia

   en.wikipedia.org/wiki/Dipeptidyl_peptidase-4...

   Dipeptidyl peptidase-4 inhibitor. DPP-4 inhibitors and GLP-1. Inhibitors of dipeptidyl peptidase 4 ( DPP-4 inhibitors or gliptins) are a class of oral hypoglycemics that block the enzyme dipeptidyl peptidase-4 (DPP-4). They can be used to treat diabetes mellitus type 2 . The first agent of the class – sitagliptin – was approved by the FDA ...

5. Semaglutide - Wikipedia

   en.wikipedia.org/wiki/Semaglutide

   In January 2023, the label for Rybelsus was updated to reflect that it can be used as a first-line treatment for adults with type 2 diabetes. [65] Grey market sellers offer unauthorized products claimed to be semaglutide online. This practice is legal in the United States as long as marketed for "research purposes only", but some buyers turn to ...

6. BioStem Receives Institutional Review Board (IRB) Approval to ...

   lite.aol.com/tech/story/0022/20240821/9217979.htm

   POMPANO BEACH, Fla., Aug. 21, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the Institutional Review Board (IRB) has approved a clinical study to evaluate Vendaje ® for diabetic foot ulcers (DFU), a key product in the ...

7. Diabetes drug in short supply after TikTok influencers tout ...

   www.aol.com/diabetes-drug-short-supply-tiktok...

   A prescription drug for diabetics is in short supply coming into the new year, and doctors are attributing part of the issue to TikTok influencers. Ozempic helps manage type 2 diabetes — but can ...